EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 23:16 ET (23-Jun-2026 03:16 GMT/UTC)

New scenarios for photonic computing: a new era of photonic AI for medical diagnosis

Editorial Office of Opto-Electronic Journals Group
Peer-Reviewed Publication

Shenzhen University researchers, with industry partners, developed a black phosphorus-based all-fiber photonic AI platform for medical diagnosis. Built around a microfiber knot resonator, a black phosphorus and molybdenum disulfide heterostructure, and a specialized architecture, the system enables low-power, high-speed optical computing. In clinical tests, it performed well in retinal detachment and liver cancer diagnosis, matching senior radiologists while greatly improving energy efficiency and latency. The work points toward scalable, sustainable photonic AI for healthcare applications.

Journal: Opto-Electronic Advances
Funder: Guangdong Province Major Project of Fundamental and Applied Fundamental Research, National Natural Science Foundation of China, Department of Science and Technology of Guangdong Province, Department of Education of Guangdong Province, Stability Support Program for Shenzhen Higher Education Institutions, Shenzhen Science and Technology Program, Shenzhen's Key Industry R&D Project, Research Team Cultivation Program of Shenzhen University, Hangzhou Normal University, Ministry of Education Key Laboratory Open Scientific Projects Fund, China National Nuclear Corporation, "Tianchi Talent” Introduction Plan

FAP-targeted radiopharmaceutical therapy shows broad effectiveness across multiple cancers

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A novel radiopharmaceutical therapy approach that targets fibroblast activation protein (FAP)—which is highly expressed on many types of cancers—is safe and effective for patients, according to a new study published in the June issue of The Journal of Nuclear Medicine. In a study of nearly 90 patients with 21 different types of cancer, FAP-targeted radiopharmaceutical therapy achieved objective responses in approximately two-thirds of patients and disease control in more than 80 percent.

Journal: Journal of Nuclear Medicine

Colorectal cancer research is placing greater emphasis on immune cells

Medical University of Vienna
Peer-Reviewed Publication

Researchers at the Medical University of Vienna have described a mechanism in metastatic colorectal cancer that has received little attention to date: a key target of existing therapies, the so-called epidermal growth factor receptor (EGFR), is likely to affect more than just the cancer cells themselves. The study shows that EGFR also influences certain immune cells in the tumour microenvironment – and thereby helps determine how effectively the body’s own defences can combat the tumour. The findings have recently been published in the journal Cell Death & Differentiation.

Journal: Cell Death and Differentiation

Finding the right target: Personalizing treatment for an aggressive asbestos-linked cancer

University of Leicester
Reports and Proceedings

A new clinical trial, led by researchers in Leicester, is investigating a new personalised treatment for patients with a rare and aggressive form of cancer, potentially giving them more time with their loved ones.

Funder: NIHR Leicester Biomedical Research Centre

Duke-NUS scientists uncover how physical activity may help protect older adults against cancer

Duke-NUS Medical School
Peer-Reviewed Publication

Duke-NUS scientists have discovered that ageing muscle may contribute to cancer growth by releasing fewer extracellular vesicles, tiny particles that cells use to communicate with one another. Their study also found that composition of these particles changes with age, weakening protective signals that help suppress tumour development. Encouragingly, exercise appears to restore this protective function.

Journal: Nature Communications

Study strengthens alcohol’s link to deadly pancreatic cancer

University of Victoria
Peer-Reviewed Publication

A new paper led by researchers at University of Victoria’s Canadian Institute for Substance Use Research (CISUR) in Canada contributes to mounting evidence that alcohol use can cause pancreatic cancer.

Journal: International Journal of Alcohol and Drug Research

Unprecedented marker uses tomography to refine gastric cancer prognosis

Fundação de Amparo à Pesquisa do Estado de São Paulo
Peer-Reviewed Publication

Scientists at the State University of Campinas have identified a variable capable of predicting patients at higher risk of unfavorable disease progression by combining data on the radiodensity of visceral fat and muscle.

Journal: Clinical Nutrition ESPEN
Funder: Fundação de Amparo à Pesquisa do Estado de São Paulo

Study identifies a new cause of age-related inflammation, suggesting promising treatment pathway

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

A new study led by researchers at The University of Texas MD Anderson Cancer Center has uncovered a previously unknown connection between nucleic acid structures called R-loops and age-related inflammation – or inflammaging – that could herald new intervention options for chronic inflammation and the subsequent health conditions.

Journal: Nature Aging

Many cancers evolve through early bursts of chromosome changes and originate from a single cancer cell

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

A comprehensive multi-cancer study from researchers at The University of Texas MD Anderson Cancer Center has revealed that cancer cells within tumors are genetically diverse, yet all carry the same core genetic changes that can be traced back to a common ancestral cell, providing a single-cell view of how tumors adapt, survive and diversify. Understanding this helps explain why some cancer cells manage to survive treatments, paving the way for more tailored diagnostic and therapeutic strategies.

Journal: Cancer Discovery

Magnus Hoffmann honored as 2026 Pew Biomedical Scholar

Gladstone Institutes
Grant and Award Announcement

The Pew Charitable Trusts has selected Gladstone Institutes Investigator Magnus Hoffmann, PhD, to join its 2026 Pew Scholars Program in the Biomedical Sciences in order to advance his work developing cancer vaccines.

Funder: Pew Charitable Trusts

4
5
6
7
8